Applying the WHO ICF Framework to the Outcome Measures Used in the Evaluation of Long-Term Clinical Outcomes in Coronavirus Outbreaks.
Activities of Daily Living
Adult
Betacoronavirus
COVID-19
Coronavirus Infections
/ diagnosis
Disability Evaluation
Humans
International Classification of Functioning, Disability and Health
Middle East Respiratory Syndrome Coronavirus
Pandemics
Patient Outcome Assessment
Pneumonia, Viral
/ diagnosis
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Severe Acute Respiratory Syndrome
/ diagnosis
World Health Organization
COVID-19
MERS
SARS
exercise tolerance
follow-up studies
lung function
mental health
outcome measures
prevalence
quality of life
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
05 09 2020
05 09 2020
Historique:
received:
03
08
2020
revised:
31
08
2020
accepted:
01
09
2020
entrez:
9
9
2020
pubmed:
10
9
2020
medline:
23
9
2020
Statut:
epublish
Résumé
(1) Objective: The World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF) classification is a unified framework for the description of health and health-related states. This study aimed to use the ICF framework to classify outcome measures used in follow-up studies of coronavirus outbreaks and make recommendations for future studies. (2) Methods: EMBASE, MEDLINE, CINAHL and PsycINFO were systematically searched for original studies assessing clinical outcomes in adult survivors of severe acute respiratory distress syndrome (SARS), middle east respiratory syndrome (MERS) and coronavirus disease-19 (COVID-19) after hospital discharge. Individual items of the identified outcome measures were linked to ICF second-level and third-level categories using ICF linking rules and categorized according to an ICF component. (3) Results: In total, 33 outcome measures were identified from 36 studies. Commonly used (a) ICF body function measures were Pulmonary Function Tests (PFT), Impact of event scale (IES-R) and Hospital Anxiety and Depression Scale (HADS); (b) ICF activity was 6-Minute Walking Distance (6MWD); (c) ICF participation measures included Short Form-36 (SF-36) and St George's Respiratory Questionnaire (SGRQ). ICF environmental factors and personal factors were rarely measured. (4) Conclusions: We recommend future COVID-19 follow-up studies to use the ICF framework to select a combination of outcome measures that capture all the components for a better understanding of the impact on survivors and planning interventions to maximize functional return.
Identifiants
pubmed: 32899534
pii: ijerph17186476
doi: 10.3390/ijerph17186476
pmc: PMC7558385
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Gen Hosp Psychiatry. 2009 Nov-Dec;31(6):546-54
pubmed: 19892213
Qual Life Res. 2006 Mar;15(2):217-31
pubmed: 16468078
Complement Ther Clin Pract. 2020 May;39:101166
pubmed: 32379637
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Respirology. 2003 Nov;8 Suppl:S36-40
pubmed: 15018132
Healthcare (Basel). 2020 May 06;8(2):
pubmed: 32384771
Eur J Phys Rehabil Med. 2009 Mar;45(1):31-6
pubmed: 18987564
Eur Spine J. 2004 Jul;13(4):314-24
pubmed: 15029489
Med Mal Infect. 2020 Aug;50(5):436-439
pubmed: 32305563
Disabil Rehabil. 2003 Jun 3-17;25(11-12):628-34
pubmed: 12959337
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Jun;17(6):329-31
pubmed: 15970093
Arch Intern Med. 2007 Jun 25;167(12):1312-20
pubmed: 17592106
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2005 Dec;17(12):740-2
pubmed: 16386183
Respir Res. 2005 Jan 08;6:5
pubmed: 15638943
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
J Rehabil Med. 2005 Jul;37(4):212-8
pubmed: 16024476
CMAJ. 2003 Jun 24;168(13):1649-60
pubmed: 12821618
J Korean Med Sci. 2018 May 10;33(24):e169
pubmed: 29892209
J Trauma Stress. 2005 Feb;18(1):39-42
pubmed: 16281194
Compr Psychiatry. 2015 Nov;63:105-12
pubmed: 26555498
J Comput Assist Tomogr. 2004 Nov-Dec;28(6):790-5
pubmed: 15538152
J Otolaryngol Head Neck Surg. 2020 May 4;49(1):26
pubmed: 32366299
Crit Care Resusc. 2006 Dec;8(4):302-8
pubmed: 17227266
Emerg Infect Dis. 2004 Feb;10(2):225-31
pubmed: 15030687
J Med Virol. 2020 Jul 30;:
pubmed: 32729939
Bone Res. 2020 Feb 14;8:8
pubmed: 32128276
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2007 Sep;19(9):536-8
pubmed: 17767822
Chest. 2005 Oct;128(4):2247-61
pubmed: 16236881
Int J Epidemiol. 2020 Jun 1;49(3):717-726
pubmed: 32086938
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Oct;25(5):529-32
pubmed: 14650151
Med Sci Monit. 2016 Aug 08;22:2793-9
pubmed: 27501327
Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):318-26
pubmed: 19555791
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Arch Neurol. 2004 Nov;61(11):1669-73
pubmed: 15534177
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Oct;25(5):512-5
pubmed: 14650147
J Rehabil Med. 2020 May 25;52(5):jrm00063
pubmed: 32449782
Hong Kong Med J. 2009 Dec;15 Suppl 8:21-3
pubmed: 20393208
Psychiatry Investig. 2019 Jan;16(1):59-64
pubmed: 30605995
Ann Phys Rehabil Med. 2020 Apr 18;:
pubmed: 32315802
J Appl Meas. 2017;18(2):122-136
pubmed: 28961149
Thorax. 2004 Oct;59(10):889-91
pubmed: 15454656
Chest. 2005 Jun;127(6):2119-24
pubmed: 15947329
Zhonghua Jie He He Hu Xi Za Zhi. 2005 Jan;28(1):10-2
pubmed: 15774184
NeuroRehabilitation. 2003;18(3):239-50
pubmed: 14530589
Chest. 2005 Sep;128(3):1393-400
pubmed: 16162734
Arch Phys Med Rehabil. 2016 Dec;97(12):2113-2122
pubmed: 27343347
Mayo Clin Proc. 2004 Nov;79(11):1372-9
pubmed: 15544014
Eur Respir J. 2004 Sep;24(3):436-42
pubmed: 15358703
Chest. 2004 Jul;126(1):149-58
pubmed: 15249456
J Rehabil Med. 2011 Feb;43(3):181-9
pubmed: 21305232
Am J Ophthalmol. 2004 Apr;137(4):773-4
pubmed: 15059730
J Tradit Chin Med. 2003 Sep;23(3):214-7
pubmed: 14535196
Can J Psychiatry. 2007 Apr;52(4):233-40
pubmed: 17500304